Food and Drug Administration
-
Madrigal Pharmaceuticals Plans $500 Million Stock Offering While Awaiting Nod from FDA
Conshohocken-based Madrigal Pharmaceuticals plans to raise $500 million while anticipating FDA approval of a groundbreaking therapy, writes John George for…
-
FDA Asked to Withdraw Approval of Harmony Biosciences’ Narcolepsy Drug; Review Pending
Scorpion Capital filed a citizens petition with the U.S. Food and Drug Administration asking to have the federal agency reverse…
-
Merck’s West Point Factory Will Help Produce Johnson & Johnson’s COVID-19 Vaccine
Merck’s factory in West Point will help produce Johnson & Johnson’s COVID-19 vaccine, writes Harold Brubaker for The Philadelphia Inquirer.…
-
FDA Places Clinical Hold on Plymouth Meeting’s Inovio’s COVID-19 Vaccine
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze…
-
Denied FDA approval for pain medication, Recro Pharma tries again
Malvern-based Recro Pharma, whose application to market a non-opioid pain medication was denied by the U.S. Food and Drug Administration,…
-
Plymouth Meeting’s Inovio Pharmaceuticals Tests Zika Vaccine on First Volunteer
Plymouth Meeting’s Inovio Pharmaceuticals has injected the first volunteer with its experimental vaccine for the Zika virus, with results from…
-
King of Prussia’s Trevena Begins Late-Stage Clinical Trials for New Pain Medicine
Trevena, a King of Prussia-based biopharmaceutical company, has started two late-stage clinical trials on its experimental pain medicine, oliceirdine, writes…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
